RecruitingNot ApplicableNCT05301348

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Sponsor

University of Arkansas

Enrollment

30 participants

Start Date

Jul 26, 2023

Study Type

INTERVENTIONAL

Conditions

Thromboembolism

Summary

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a new way to detect blood clots circulating in the bloodstream in real time using a special device. It could help doctors better monitor and treat conditions like blood clots in the veins or lungs, or strokes caused by clots. You may be eligible if... - You are 18 or older - You have been diagnosed with a venous or arterial blood clot (thromboembolism) or acute ischemic stroke - You can provide informed consent You may NOT be eligible if... - You have a pulmonary embolism requiring mechanical ventilation - You have an acute coronary syndrome (heart attack or unstable angina) - You have a clot inside the heart - You are pregnant or breastfeeding - You have sickle cell crisis, active severe infection, or sepsis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.